The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2. - Wikidata - awgldk - TriplyDB

The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.

The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.

http://www.wikidata.org/entity/Q37228131

about

Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway.The endotoxemia cardiac dysfunction is attenuated by AMPK/mTOR signaling pathway regulating autophagy.Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease

P2860

Q37123324-E02433D8-4CF3-46F8-B8A2-99EC5C778D96 Q47953743-C5945CD5-7BC8-4C53-AE4B-785804620DD0 Q58698789-52153EE2-0DB7-4E03-9473-73CE8CC599F9

P2860

The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.

http://www.wikidata.org/entity/Q37228131

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@en

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@nl

type

label

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@en

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@nl

prefLabel

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@en

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@nl

P1433

Q37228131-2DB47566-8164-4621-B4FC-C0B2087AE98D

P1476

Q37228131-F53639EA-A9AA-4C4B-81A6-FB6E4B054A60

P2093

Q37228131-115DEEB0-0B89-49B9-B4FE-E04E8D06B319

Q37228131-16FEBA8A-91B2-48AD-9A5F-780470A898D5

Q37228131-511C00F8-1223-485C-AB39-6DB03267EC1A

Q37228131-54A096E6-0030-44B3-B01C-3453B8B05FB7

Q37228131-5A8AC83D-C22A-4036-8151-93726695A52D

Q37228131-6DF81B6A-53D9-4C40-8FA0-8EE5912F53B6

Q37228131-71429EAC-E54F-49C6-8631-87F3B5F64A4F

Q37228131-9708CCFE-49D0-4459-BAB4-254B947AE574

Q37228131-A804DCA7-F6A4-4C15-A16F-B7CE578E07F9

Q37228131-BC881F9F-4E33-4600-A169-2544E49E0254

P2860

Q37228131-092F9E33-2FD9-4CC0-8B18-FBCFCD800045

Q37228131-0CFF6255-6C2D-4496-88B1-6C9218DED775

Q37228131-0DB96A4D-8F57-4841-8D97-E491CC9326A2

Q37228131-0FAA3AED-3C64-416D-B9DE-722FC0C07546

Q37228131-1A40225D-A18F-41D5-ADD6-BAE26F28FD67

Q37228131-22449968-2A1F-4137-AC11-9F63C85A8120

Q37228131-28388CF4-1891-4FAA-A211-D4322182CB07

Q37228131-29A40F08-3DBD-41CF-931A-9066E300A195

Q37228131-32BFFA7F-6D64-4FB5-9807-3753EB76E081

Q37228131-34166AFD-7D0B-4C86-87E6-3BE26F6AAF62

P304

Q37228131-888B045D-0211-4050-86FA-C2863AA3AF25

P31

Q37228131-8E9F76E8-2E21-43EC-B9E3-4D9181A267BF

P356

Q37228131-2C06AE4D-0279-4D20-86F3-2E091B4E9842

P433

Q37228131-240FD953-E917-4CE4-BF72-45F573EDF91D

P478

Q37228131-F7EBA12E-EA04-4B42-8BC2-C0344387280B

P577

Q37228131-CD55DEE6-8417-40D2-810B-D8CB8C2816F8

P698

Q37228131-86E97B92-87CE-4AB2-9C32-C9FBE3437818

P921

Q37228131-C16E8C8A-F09D-435E-BF6A-7FFB0662E8E6

P932

Q37228131-55B0E881-E6CC-49DB-8752-61935DB5A45C

P356

P1433

Toxicological Sciences

P1476

The Modulation of Cardiac Cont ...... logical Effects of Urocortin2.

@en

P2093

Bo Xu

http://www.w3.org/2001/XMLSchema#string

Ji Li

http://www.w3.org/2001/XMLSchema#string

Jiyan Leng

http://www.w3.org/2001/XMLSchema#string

Lin Wang

http://www.w3.org/2001/XMLSchema#string

Nanhu Quan

http://www.w3.org/2001/XMLSchema#string

Quan Liu

http://www.w3.org/2001/XMLSchema#string

Si Chen

http://www.w3.org/2001/XMLSchema#string

Wanqing Sun

http://www.w3.org/2001/XMLSchema#string

Xiangquan Mi

http://www.w3.org/2001/XMLSchema#string

Xingchi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia

A preferred AMPK phosphorylation site adjacent to the inhibitory loop of cardiac and skeletal troponin I

Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart

Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis

Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart

P304

581-593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/TOXSCI/KFV202

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26342213

http://www.w3.org/2001/XMLSchema#string

P921

P932

5009442

http://www.w3.org/2001/XMLSchema#string